Literature DB >> 33713026

Central pontine myelinolysis and the osmotic demyelination syndromes: an open and shut case?

Pyari Bose1.   

Abstract

Central pontine myelinolysis and extrapontine myelinolysis are collectively called the osmotic demyelination syndromes. Despite being described in 1959, there are several aspects of the disorder that remain an enigma. Animal models and neuroimaging techniques have allowed us to understand the condition better. From being a universally fatal disorder that was diagnosed post mortem, increased awareness, neuroimaging techniques and supportive care have enabled us to make the diagnosis ante-mortem. This has also led to a significant drop in associated mortality. The aim of this review is to highlight the clinical spectrum, neuroimaging findings, and recent developments.
© 2021. Belgian Neurological Society.

Entities:  

Mesh:

Year:  2021        PMID: 33713026     DOI: 10.1007/s13760-021-01634-0

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  48 in total

1.  Asymptomatic central pontine myelinolysis.

Authors:  M U Strub; A J Steck; P Fuhr
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

Review 2.  Central pontine and extrapontine myelinolysis in children: a review of 76 patients.

Authors:  Adrianna M Ranger; Navjot Chaudhary; Michael Avery; Douglas Fraser
Journal:  J Child Neurol       Date:  2012-05-30       Impact factor: 1.987

3.  Asymptomatic pontine myelinolysis.

Authors:  S S M Razvi; J P Leach
Journal:  Eur J Neurol       Date:  2006-11       Impact factor: 6.089

Review 4.  Central pontine myelinolysis.

Authors:  Christian Lampl; Kambiz Yazdi
Journal:  Eur Neurol       Date:  2002       Impact factor: 1.710

5.  Central pontine myelinolysis at autopsy; a twelve year retrospective analysis.

Authors:  K L Newell; B K Kleinschmidt-DeMasters
Journal:  J Neurol Sci       Date:  1996-10       Impact factor: 3.181

6.  Osmotic Demyelination Syndrome With Evolving Movement Disorders.

Authors:  Ai Huey Tan; Shen-Yang Lim; Rong Xiang Ng
Journal:  JAMA Neurol       Date:  2018-07-01       Impact factor: 18.302

7.  Central pontine myelinolysis without hyponatraemia.

Authors:  P Bose; A Kunnacherry; P Maliakal
Journal:  J R Coll Physicians Edinb       Date:  2011-09

8.  Central pontine myelinolysis. Considerations on etiology, diagnosis, and treatment.

Authors:  B Messert; W W Orrison; M J Hawkins; C E Quaglieri
Journal:  Neurology       Date:  1979-02       Impact factor: 9.910

9.  Central pontine myelinolysis and abnormalities in serum sodium.

Authors:  U T Slager
Journal:  Clin Neuropathol       Date:  1986 Nov-Dec       Impact factor: 1.368

10.  A case of chronic asymptomatic central pontine myelinolysis with histological evidence of remyelination.

Authors:  Harry R Haynes; Patrick J Gallagher; Andrea Cordaro; Marcus Likeman; Seth Love
Journal:  Forensic Sci Med Pathol       Date:  2017-11-25       Impact factor: 2.007

View more
  2 in total

1.  Application of aptamers in regenerative medicine.

Authors:  Zhaohui Luo; Shimin Chen; Jing Zhou; Chong Wang; Kai Li; Jia Liu; Yujin Tang; Liqiang Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-08-29

2.  Development of Parkinsonism in a Patient with Central Pontine Myelinolysis.

Authors:  Annibale Antonioni; Vittorio Rispoli; Patrik Fazio; Nico Golfrè Andreasi; Vittorio Govoni; Enrico Granieri
Journal:  Neurol Int       Date:  2022-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.